Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1988 1
1989 1
1995 1
1996 2
2006 1
2007 1
2014 2
2015 1
2016 1
2017 2
2018 3
2019 2
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy.
Shibuya H, Hijioka S, Sakamoto Y, Ito T, Ueda K, Komoto I, Kobayashi N, Kudo A, Yasuda H, Miyake H, Arita J, Kiritani S, Ikeda M, Imaoka H, Ueno M, Kobayashi S, Furuta M, Nagashio Y, Murohisa G, Aoki T, Matsumoto S, Motoya M, Azemoto N, Itakura J, Horiguchi S, Yogi T, Kawagoe T, Miyaoka Y, Imamura F, Senju M, Arioka H, Hara K, Imamura M, Okusaka T. Shibuya H, et al. Among authors: motoya m. Cancer Chemother Pharmacol. 2018 Oct;82(4):661-668. doi: 10.1007/s00280-018-3656-y. Epub 2018 Jul 27. Cancer Chemother Pharmacol. 2018. PMID: 30054710 Clinical Trial.
Phase 2 Study of Neoadjuvant Treatment of Sequential S-1-Based Concurrent Chemoradiation Therapy Followed by Systemic Chemotherapy with Gemcitabine for Borderline Resectable Pancreatic Adenocarcinoma (HOPS-BR 01).
Hayashi T, Nakamura T, Kimura Y, Yoshida M, Someya M, Kawakami H, Sakuhara Y, Katoh N, Takahashi K, Ambo Y, Miura K, Motoya M, Tanaka E, Murakawa K, Yamabuki T, Yamazaki H, Katanuma A, Hirano S; Hokkaido Pancreatic Study Group. Hayashi T, et al. Among authors: motoya m. Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):606-617. doi: 10.1016/j.ijrobp.2019.07.004. Epub 2019 Jul 12. Int J Radiat Oncol Biol Phys. 2019. PMID: 31306735 Clinical Trial.
Clinical usefulness of conversion surgery for unresectable pancreatic cancer diagnosed on multidetector computed tomography imaging: Results from a multicenter observational cohort study by the Hokkaido Pancreatic Cancer Study Group (HOPS UR-01).
Kimura Y, Nakamura T, Hayashi T, Kuwatani M, Motoya M, Yoshida M, Imamura M, Nagayama M, Yamaguchi H, Yamakita K, Goto T, Sakuhara Y, Takahashi K, Maguchi H, Hirano S, Takemasa I. Kimura Y, et al. Among authors: motoya m. Ann Gastroenterol Surg. 2019 Jul 9;3(5):523-533. doi: 10.1002/ags3.12272. eCollection 2019 Sep. Ann Gastroenterol Surg. 2019. PMID: 31549012 Free PMC article.
MicroRNA-31 reflects IL-6 expression in cancer tissue and is related with poor prognosis in bile duct cancer.
Ishigami K, Nosho K, Koide H, Kanno S, Mitsuhashi K, Igarashi H, Shitani M, Motoya M, Kimura Y, Hasegawa T, Kaneto H, Takemasa I, Suzuki H, Nakase H. Ishigami K, et al. Among authors: motoya m. Carcinogenesis. 2018 Sep 21;39(9):1127-1134. doi: 10.1093/carcin/bgy075. Carcinogenesis. 2018. PMID: 29860474
Ectopic relapse of IgG4-related disease presenting as IgG4-related sclerosing cholecystitis: A case report and review of literature.
Ishigami K, Shitani M, Kimura Y, Hasegawa T, Masaki Y, Ito A, Akutsu N, Yamamoto M, Motoya M, Sasaki S, Takahashi H, Takemasa I, Nakase H. Ishigami K, et al. Among authors: motoya m. Medicine (Baltimore). 2018 Dec;97(52):e13868. doi: 10.1097/MD.0000000000013868. Medicine (Baltimore). 2018. PMID: 30593191 Free PMC article.
MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.
Kanno S, Nosho K, Ishigami K, Yamamoto I, Koide H, Kurihara H, Mitsuhashi K, Shitani M, Motoya M, Sasaki S, Tanuma T, Maguchi H, Hasegawa T, Kimura Y, Takemasa I, Shinomura Y, Nakase H. Kanno S, et al. Among authors: motoya m. Carcinogenesis. 2017 Apr 1;38(4):425-431. doi: 10.1093/carcin/bgx013. Carcinogenesis. 2017. PMID: 28186267
The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy.
Matsunaga Y, Adachi Y, Sasaki Y, Koide H, Motoya M, Nosho K, Takagi H, Yamamoto H, Sasaki S, Arimura Y, Tokino T, Carbone DP, Imai K, Shinomura Y. Matsunaga Y, et al. Among authors: motoya m. Mol Carcinog. 2017 Feb;56(2):515-526. doi: 10.1002/mc.22513. Epub 2016 Jun 23. Mol Carcinog. 2017. PMID: 27312358
Clinical Outcomes of Biliary Drainage during a Neoadjuvant Therapy for Pancreatic Cancer: Metal versus Plastic Stents.
Kuwatani M, Nakamura T, Hayashi T, Kimura Y, Ono M, Motoya M, Imai K, Yamakita K, Goto T, Takahashi K, Maguchi H, Hirano S; Hokkaido Pancreatic Cancer Study Group (HOPS). Kuwatani M, et al. Among authors: motoya m. Gut Liver. 2020 Mar 15;14(2):269-273. doi: 10.5009/gnl18573. Gut Liver. 2020. PMID: 31060118 Free PMC article.
Development of hypertension within 2 weeks of initiation of sorafenib for advanced hepatocellular carcinoma is a predictor of efficacy.
Akutsu N, Sasaki S, Takagi H, Motoya M, Shitani M, Igarashi M, Hirayama D, Wakasugi H, Yamamoto H, Kaneto H, Yonezawa K, Yawata A, Adachi T, Hamamoto Y, Shinomura Y. Akutsu N, et al. Among authors: motoya m. Int J Clin Oncol. 2015 Feb;20(1):105-10. doi: 10.1007/s10147-014-0691-5. Epub 2014 Apr 18. Int J Clin Oncol. 2015. PMID: 24744262
New instrument for measuring multiple domains of social cognition: construct validity of the Social Cognition Screening Questionnaire (Japanese version).
Kanie A, Hagiya K, Ashida S, Pu S, Kaneko K, Mogami T, Oshima S, Motoya M, Niwa S, Inagaki A, Ikebuchi E, Kikuchi A, Yamasaki S, Iwata K, Roberts DL, Nakagome K. Kanie A, et al. Among authors: motoya m. Psychiatry Clin Neurosci. 2014 Sep;68(9):701-11. doi: 10.1111/pcn.12181. Epub 2014 Apr 22. Psychiatry Clin Neurosci. 2014. PMID: 24612235 Free article.
20 results
Jump to page
Feedback